Scholarlink

Background <p>Minimally invasive cosmetic procedures such as dermabrasion, fat grafting, and fibrous septa release have gained popularity for addressing various aesthetic concerns, including skin texture irregularities, volume loss, and cellulite. This study aimed to evaluate the efficacy, safety, and patient satisfaction associated with these procedures.</p> Methods <p>A retrospective study was conducted on 150 patients who underwent dermabrasion, fat grafting, or fibrous septa release between January 2021 and December 2022. Patient data were obtained from hospital records and included demographic details, pre- and post-procedure photographs, complication rates, and patient satisfaction scores measured using the FACE-Q Satisfaction with Appearance Scale. Comparative statistical analyses were performed to evaluate outcomes.</p> Results <p>Dermabrasion led to improvement in 86% (<i>n</i> = 43) of patients, primarily in skin texture and acne scars, with mild erythema observed in 12% (<i>n</i> = 6). Fat grafting yielded successful volume restoration in 90% (<i>n</i> = 45), with minor fat absorption in 8% (<i>n</i> = 4). Fibrous septa release improved cellulite appearance in 80% (<i>n</i> = 40) of patients, though 24% (<i>n</i> = 12) experienced transient bruising. Patient satisfaction scores were highest for fat grafting (mean = 8.9 ± 0.6), followed by dermabrasion (8.3 ± 0.9) and fibrous septa release (7.8 ± 1.1) (<i>p</i> = 0.03).</p> Conclusion <p>Each procedure demonstrated efficacy in treating specific aesthetic conditions. Dermabrasion is most effective for surface-level skin imperfections, fat grafting for volume enhancement, and fibrous septa release for cellulite reduction. All showed acceptable safety profiles and high patient satisfaction. Future prospective studies with larger cohorts and long-term follow-up are recommended to validate these findings.</p> Level of Evidence II <p>This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors <a href="http://www.springer.com/00266">www.springer.com/00266</a>.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Evaluating the Efficacy of Dermabrasion, Fat Grafting, and Fibrous Septa Release: A Clinical Study

  • 期刊论文

  • 发表日期：

    2026年4月21日

查看全文
  • Faysal Saud Shaeer

摘要

Background

Minimally invasive cosmetic procedures such as dermabrasion, fat grafting, and fibrous septa release have gained popularity for addressing various aesthetic concerns, including skin texture irregularities, volume loss, and cellulite. This study aimed to evaluate the efficacy, safety, and patient satisfaction associated with these procedures.

Methods

A retrospective study was conducted on 150 patients who underwent dermabrasion, fat grafting, or fibrous septa release between January 2021 and December 2022. Patient data were obtained from hospital records and included demographic details, pre- and post-procedure photographs, complication rates, and patient satisfaction scores measured using the FACE-Q Satisfaction with Appearance Scale. Comparative statistical analyses were performed to evaluate outcomes.

Results

Dermabrasion led to improvement in 86% (n = 43) of patients, primarily in skin texture and acne scars, with mild erythema observed in 12% (n = 6). Fat grafting yielded successful volume restoration in 90% (n = 45), with minor fat absorption in 8% (n = 4). Fibrous septa release improved cellulite appearance in 80% (n = 40) of patients, though 24% (n = 12) experienced transient bruising. Patient satisfaction scores were highest for fat grafting (mean = 8.9 ± 0.6), followed by dermabrasion (8.3 ± 0.9) and fibrous septa release (7.8 ± 1.1) (p = 0.03).

Conclusion

Each procedure demonstrated efficacy in treating specific aesthetic conditions. Dermabrasion is most effective for surface-level skin imperfections, fat grafting for volume enhancement, and fibrous septa release for cellulite reduction. All showed acceptable safety profiles and high patient satisfaction. Future prospective studies with larger cohorts and long-term follow-up are recommended to validate these findings.

Level of Evidence II

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.